Tue, February 15, 2011
Mon, February 14, 2011
Fri, February 11, 2011
Thu, February 10, 2011
Wed, February 9, 2011
Tue, February 8, 2011
Mon, February 7, 2011
[ Mon, Feb 07th 2011 ] - Market Wire
00 A.M. EST
Sun, February 6, 2011
Fri, February 4, 2011
Thu, February 3, 2011
Wed, February 2, 2011
Tue, February 1, 2011
Mon, January 31, 2011
Sun, January 30, 2011
Fri, January 28, 2011
Thu, January 27, 2011
Wed, January 26, 2011

BG Medicine Announces Pricing of Initial Public Offering


//health-fitness.news-articles.net/content/2011/ .. nnounces-pricing-of-initial-public-offering.html
Published in Health and Fitness on Friday, February 4th 2011 at 18:40 GMT by Market Wire   Print publication without navigation


WALTHAM, Mass.--([ BUSINESS WIRE ])--BG Medicine (NASDAQ: BGMD) today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price of $7.00 per share, before underwriting discounts and commissions. All shares are being sold by the Company. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol "BGMD." In addition, the underwriters have been granted a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.

Lazard Capital Markets LLC is acting as the sole bookrunning manager for the initial public offering, and Baird and Cowen and Company are acting as co-managers.

A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on February 3, 2011. This offering is being made solely by means of a written prospectus, a copy of which may be obtained from Lazard Capital Markets LLC by mail at 30 Rockefeller Plaza, 60th Floor, New York, NY 10020, Attention: Syndicate Department, or by calling toll-free (800) 542-0970.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About BG Medicine

BG Medicine is a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs.


Publication Contributing Sources